Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie最新文献

筛选
英文 中文
STING-inhibitor-phenamil polymeric nanocarriers for the in vitro modulation of macrophage polarization. sting抑制剂-非那米聚合物纳米载体对巨噬细胞极化的体外调节。
IF 7.5
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Pub Date : 2026-11-11 DOI: 10.1016/j.biopha.2026.120036
Gabriel S Harris, Abigail C Alexander, Titania N Bethiana, Shrinidhi Ravi, Kofi B Owusu, Herman O Sintim, Kurt D Ristroph, Marxa L Figueiredo
{"title":"STING-inhibitor-phenamil polymeric nanocarriers for the in vitro modulation of macrophage polarization.","authors":"Gabriel S Harris, Abigail C Alexander, Titania N Bethiana, Shrinidhi Ravi, Kofi B Owusu, Herman O Sintim, Kurt D Ristroph, Marxa L Figueiredo","doi":"10.1016/j.biopha.2026.120036","DOIUrl":"https://doi.org/10.1016/j.biopha.2026.120036","url":null,"abstract":"<p><p>Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation and polyarthritis. RA has no cure and imposes a significant burden on individuals because current standard-of-care anti-inflammatory treatments reduce inflammation by regulating lymphocyte proliferation and pro-inflammatory cytokine function. However, recent studies have shown that macrophages play a pivotal role in the progression of RA and therefore, we hypothesize that co-loaded nanocarriers (NCs) containing a STING inhibitor and phenamil can reduce inflammation by repolarizing macrophages from a pro-inflammatory (M1-like) to an anti-inflammatory (M2-like) phenotype. Using Flash NanoPrecipitation (FNP), both compounds were encapsulated into polymeric nanocarriers which were then tested for their ability to induce an anti-inflammatory phenotype in vitro. Macrophage NF-κB activation levels were assessed using a reporter cell line, gene expression via qRT-PCR, and polarization state via flow cytometry. NF-κB activity was monitored using a cell line that secretes embryonic alkaline phosphatase upon activation; reductions in this signal indicate suppression of inflammatory signaling. Key markers examined for an anti-inflammatory phenotype for macrophages included IL-1β, IL-6, IL-10, and TGF-β. Finally, by assessing the ratio of M2-like to M1-like macrophages, we sought to determine if these formulations could successfully repolarize macrophages from M1-like to M2-like, and/or help macrophages resist polarization to an M1-like state following exposure to a pro-inflammatory stimulus. Through this work, we aimed to investigate how nanotechnology can be leveraged to improve therapeutic outcomes by regulating macrophage polarization states.</p>","PeriodicalId":93904,"journal":{"name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","volume":"205 ","pages":"120036"},"PeriodicalIF":7.5,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149396558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fourth-generation multi-costimulatory chimeric antigen receptor T cells targeting CD133 and integrin αvβ6 exert potent antitumor activity in cholangiocarcinoma. 靶向CD133和整合素αvβ6的第四代多共刺激嵌合抗原受体T细胞在胆管癌中发挥了强大的抗肿瘤活性。
IF 7.5
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Pub Date : 2026-11-10 DOI: 10.1016/j.biopha.2026.120045
Tullayakorn Plengsuriyakarn, Thanich Sangsuwannukul, Kamonlapat Supimon, Chalermchai Somboonpatarakun, Mutita Junking, Pa-Thai Yenchitsomanus, Kesara Na-Bangchang
{"title":"Fourth-generation multi-costimulatory chimeric antigen receptor T cells targeting CD133 and integrin αvβ6 exert potent antitumor activity in cholangiocarcinoma.","authors":"Tullayakorn Plengsuriyakarn, Thanich Sangsuwannukul, Kamonlapat Supimon, Chalermchai Somboonpatarakun, Mutita Junking, Pa-Thai Yenchitsomanus, Kesara Na-Bangchang","doi":"10.1016/j.biopha.2026.120045","DOIUrl":"https://doi.org/10.1016/j.biopha.2026.120045","url":null,"abstract":"<p><p>Cholangiocarcinoma (CCA) is an aggressive and highly metastatic malignancy with limited responsiveness to conventional chemotherapy, underscoring the need for innovative therapeutic strategies. This study aimed to develop and evaluate fourth-generation chimeric antigen receptor (CAR) T cells (CAR4; a multi-costimulatory CD28/4-1BB/CD27/CD3ζ design without a cytokine or other transgene payload) targeting CD133 and integrin αvβ6 to treat CCA. Two parallel CAR T-cell products, each incorporating a single antigen-recognition domain, were generated and evaluated independently rather than as one bispecific construct. We transduced activated human T lymphocytes with lentiviral constructs encoding anti-CD133 CAR4 and an integrin-targeted CAR (A20 CAR4), confirmed CAR expression by flow cytometry, then expanded them in vitro and evaluated therapeutic efficacy after intratumoral administration in a CCA xenograft nude mouse model. CAR4 T-cell treatment produced dose-dependent suppression of tumor growth and significant prolongation of survival compared with control and untreated groups. High-dose anti-CD133 and anti-integrin CAR4 T cells achieved greater tumor inhibition and numerically extended median survival beyond that observed with cisplatin. Histopathological analysis revealed no treatment-related abnormalities in heart, liver, spleen, or kidney tissues, and lung metastasis incidence was markedly reduced in high-dose CAR-treated groups. Quantitative real-time PCR analysis demonstrated coordinated downregulation of genes associated with angiogenesis (VEGF), matrix remodeling (MMP9), inflammatory signaling (COX-2, mPGES-1, TNF-α, IL-6), and immunosuppressive pathways (TGF-β, IL-10). These findings indicate that fourth-generation CAR T cells targeting CD133 and integrin αvβ6 exert potent antitumor activity in this model and that their activity is associated with transcript-level downregulation of tumor microenvironment-related genes, suggesting potential modulation of the tumor microenvironment that will require protein-level and functional confirmation. Antigen-dependent cytotoxicity was not directly assessed in vitro in the present study. Together, these data support further translational development of multi-costimulatory CAR T-cell platforms for CCA.</p>","PeriodicalId":93904,"journal":{"name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","volume":"205 ","pages":"120045"},"PeriodicalIF":7.5,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149389008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early-stage inhibition of HIV-1 subtypes A, B, and C gag- protease chimeras by Penicillium chrysogenum P03MB2 metabolites and activity against cell-to-cell spread. 青霉菌P03MB2代谢物早期抑制HIV-1亚型A、B和C gag-蛋白酶嵌合体及抗细胞间传播活性
IF 7.5
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Pub Date : 2026-11-10 DOI: 10.1016/j.biopha.2026.120033
Aphiwe P Gumede, Darian Naidu, Kensane Mthembu, Murunwa Maimela, Omolara O Baiyegunhi, Nompumelelo P Mkhwanazi
{"title":"Early-stage inhibition of HIV-1 subtypes A, B, and C gag- protease chimeras by Penicillium chrysogenum P03MB2 metabolites and activity against cell-to-cell spread.","authors":"Aphiwe P Gumede, Darian Naidu, Kensane Mthembu, Murunwa Maimela, Omolara O Baiyegunhi, Nompumelelo P Mkhwanazi","doi":"10.1016/j.biopha.2026.120033","DOIUrl":"https://doi.org/10.1016/j.biopha.2026.120033","url":null,"abstract":"<p><p>Despite the success of antiretroviral therapy, human immunodeficiency virus type 1 (HIV-1) cell-to-cell spread remains a major barrier to viral eradication. This study evaluated the antiviral activity of secondary metabolite fractions derived from Penicillium chrysogenum P03MB2 against cell-free HIV-1 infection of patient-derived Gag-protease chimeric viruses representing HIV-1 subtypes A, B, and C, and investigated its impact on cell-to-cell spread. Crude fungal extracts from oat-grown cultures were fractionated using mixed-mode cation exchange (MCX) solid-phase extraction. Cytotoxicity was assessed in TZM-bl cells by MTT assay, antiviral activity was evaluated using a luciferase reporter assay. In silico molecular docking explored predicted interactions between five identified metabolites, including Cytochalasin J, and entry-associated targets (CCR5, CXCR4, and gp120). Cell- to cell transmission was assessed using Jurkat co-culture assays and flow cytometry. The 45% MCX Oats fraction emerged as the most active candidate exhibiting low cytotoxicity (CC₅₀ > 300 µg/mL) and potent antiviral activity across all chimeric variants (IC₅₀: 0.221-1.007 µg/mL; Selectivity Indices: 271-1235). Time-of-addition analysis indicated that maximal inhibition during the early infection stages. Molecular docking identified favourable predicted binding compatibility for Cytochalasin J against CCR5 (reaching -10.9 kcal/mol), CXCR4, and gp120 targets, sharing predicted interacting residues with reference drugs. Furthermore, the fraction significantly reduces newly infected target cells in the cell-to-cell transmission model compared to untreated controls. Collectively, these findings demonstrate that 45% MCX Oats fraction exhibits potent antiviral activity against cross-clade antiviral activity against HIV-1 Gag-Pro chimeras and limits viral transmission in vitro, supporting further bioassay-guided isolation of its active constituents.</p>","PeriodicalId":93904,"journal":{"name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","volume":"205 ","pages":"120033"},"PeriodicalIF":7.5,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149389007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formononetin disrupts MRSA biofilm via potential SarA-associated regulatory modulation. 刺芒柄花素通过潜在的sara相关的调节调节破坏MRSA生物膜。
IF 7.5
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Pub Date : 2026-11-09 DOI: 10.1016/j.biopha.2026.120028
Atlanta Borah, Jashaswi Priyadarshini Jena, Macha Vijay, Annie Okram, Gowtham M, Niveditha P, Sukhadeo B Barbuddhe, Nagendra R Hegde, Deepak B Rawool, Anand Srivastava
{"title":"Formononetin disrupts MRSA biofilm via potential SarA-associated regulatory modulation.","authors":"Atlanta Borah, Jashaswi Priyadarshini Jena, Macha Vijay, Annie Okram, Gowtham M, Niveditha P, Sukhadeo B Barbuddhe, Nagendra R Hegde, Deepak B Rawool, Anand Srivastava","doi":"10.1016/j.biopha.2026.120028","DOIUrl":"https://doi.org/10.1016/j.biopha.2026.120028","url":null,"abstract":"<p><p>Biofilm formation is a crucial aspect of Methicillin-resistant Staphylococcus aureus (MRSA) pathogenesis and contributes to its resistance against conventional antibiotics. This study reports the identification of a bioactive molecule, formononetin, from Glycyrrhiza glabra L., that is effective against MRSA. Formononetin significantly inhibited biofilm formation, disrupted sessile biofilm, and reduced the hemolytic activity of MRSA in a dose-dependent manner. Formononetin also increased the survival rate of MRSA-infected G. mellonella larvae by decreasing the bacterial load and increasing melanization. The combination of formononetin with antibiotics, like oxacillin, ampicillin, and streptomycin, showed a fractional inhibitory concentration index (FICI) ≤ 0.5, which indicates a synergistic effect. Molecular docking studies showed formononetin can bind to the global regulator, SarA, with an estimated binding score of -6.176 kcal/mol. Further, the aspartate residue (D20) in SarA was identified as a binding site for formononetin. Microscale thermophoresis and electrophoretic mobility shift assay of the SarAD20A mutant showed reduced affinity towards formononetin without affecting its DNA-binding activity compared to its wild-type counterpart. Further, proteomic profiling of MRSA upon treatment with formononetin showed significant modulation of SarA and SarA-related pathways, such as scdA and agrC. Our findings suggest that formononetin holds promise as a natural agent for combating MRSA biofilm.</p>","PeriodicalId":93904,"journal":{"name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","volume":"205 ","pages":"120028"},"PeriodicalIF":7.5,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149382277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Therapeutic promises of ginkgolide A: A literature-based review" [Biomed. Pharmacother. 132 (2020) 110908]. “银杏内酯A的治疗前景:基于文献的回顾”的更正[生物医学杂志]。药理学杂志,132(2020):110908。
IF 7.5
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Pub Date : 2026-11-06 DOI: 10.1016/j.biopha.2026.120031
Chandan Sarkar, Cristina Quispe, Sarmin Jamaddar, Rajib Hossain, Pranta Ray, Milon Mondal, Zeinab Abdulwanis Mohamed, Mohammed Sani Jaafaru, Bahare Salehi, Muhammad Torequl Islam, Ahmad Faizal Abdull Razis, Miquel Martorell, Edgar Pastene-Navarrete, Javad Sharifi-Rad
{"title":"Corrigendum to \"Therapeutic promises of ginkgolide A: A literature-based review\" [Biomed. Pharmacother. 132 (2020) 110908].","authors":"Chandan Sarkar, Cristina Quispe, Sarmin Jamaddar, Rajib Hossain, Pranta Ray, Milon Mondal, Zeinab Abdulwanis Mohamed, Mohammed Sani Jaafaru, Bahare Salehi, Muhammad Torequl Islam, Ahmad Faizal Abdull Razis, Miquel Martorell, Edgar Pastene-Navarrete, Javad Sharifi-Rad","doi":"10.1016/j.biopha.2026.120031","DOIUrl":"https://doi.org/10.1016/j.biopha.2026.120031","url":null,"abstract":"","PeriodicalId":93904,"journal":{"name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","volume":" ","pages":"120031"},"PeriodicalIF":7.5,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149358445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "Revolution in biomedicine using emerging of picomaterials: A breakthrough on the future of medical diagnosis and therapy" [BIOPHA, 120 (2019), 109484]. “新型微材料在生物医学中的应用:未来医学诊断和治疗的突破”[j].中国生物医学工程学报,2019,29(4):1094 - 1094。
IF 7.5
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Pub Date : 2026-11-06 DOI: 10.1016/j.biopha.2026.120032
Paria Pashazadeh-Panahi, Mohammad Hasanzadeh
{"title":"Corrigendum to \"Revolution in biomedicine using emerging of picomaterials: A breakthrough on the future of medical diagnosis and therapy\" [BIOPHA, 120 (2019), 109484].","authors":"Paria Pashazadeh-Panahi, Mohammad Hasanzadeh","doi":"10.1016/j.biopha.2026.120032","DOIUrl":"https://doi.org/10.1016/j.biopha.2026.120032","url":null,"abstract":"","PeriodicalId":93904,"journal":{"name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","volume":" ","pages":"120032"},"PeriodicalIF":7.5,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149358444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to "Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications" [Biomedicine & Pharmacotherapy 162 (2023) 114687]. “迷迭香酸及其衍生物:抗癌潜力和其他生物医学应用的最新见解”[生物医学与药物治疗162(2023)114687]。
IF 7.5
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Pub Date : 2026-08-01 Epub Date: 2026-05-13 DOI: 10.1016/j.biopha.2026.119513
Shumaila Ijaz, Javed Iqbal, Banzeer Ahsan Abbasi, Zakir Ullah, Tabassum Yaseen, Sobia Kanwal, Tariq Mahmood, Sandugash Sydykbayeva, Alibek Ydyrys, Zainab M Almarhoon, Javad Sharifi-Rad, Christophe Hano, Daniela Calina, William C Cho
{"title":"Retraction notice to \"Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications\" [Biomedicine & Pharmacotherapy 162 (2023) 114687].","authors":"Shumaila Ijaz, Javed Iqbal, Banzeer Ahsan Abbasi, Zakir Ullah, Tabassum Yaseen, Sobia Kanwal, Tariq Mahmood, Sandugash Sydykbayeva, Alibek Ydyrys, Zainab M Almarhoon, Javad Sharifi-Rad, Christophe Hano, Daniela Calina, William C Cho","doi":"10.1016/j.biopha.2026.119513","DOIUrl":"10.1016/j.biopha.2026.119513","url":null,"abstract":"","PeriodicalId":93904,"journal":{"name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","volume":" ","pages":"119513"},"PeriodicalIF":7.5,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147936197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to "Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation" [Biomedicine & Pharmacotherapy 155 (2022) 113740]. “胶质母细胞瘤多形性治疗的最新进展:关注自噬调节”[生物医学与药物治疗]155(2022)113740]。
IF 7.5
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Pub Date : 2026-08-01 Epub Date: 2026-06-24 DOI: 10.1016/j.biopha.2026.119688
Mehdi Sanati, Maryam Moradi Binabaj, Seyed Sajad Ahmadi, Samaneh Aminyavari, Hossein Javid, Hamid Mollazadeh, Bahram Bibak, Elmira Mohtashami, Tannaz Jamialahmadi, Amir R Afshari, Amirhossein Sahebkar
{"title":"Retraction notice to \"Recent advances in glioblastoma multiforme therapy: A focus on autophagy regulation\" [Biomedicine & Pharmacotherapy 155 (2022) 113740].","authors":"Mehdi Sanati, Maryam Moradi Binabaj, Seyed Sajad Ahmadi, Samaneh Aminyavari, Hossein Javid, Hamid Mollazadeh, Bahram Bibak, Elmira Mohtashami, Tannaz Jamialahmadi, Amir R Afshari, Amirhossein Sahebkar","doi":"10.1016/j.biopha.2026.119688","DOIUrl":"10.1016/j.biopha.2026.119688","url":null,"abstract":"","PeriodicalId":93904,"journal":{"name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","volume":" ","pages":"119688"},"PeriodicalIF":7.5,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148321173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to "Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers" [Biomedicine & Pharmacotherapy 181 (2024) 117714]. “解读肿瘤微环境:EMT在乳腺癌转移和治疗耐药中的调节作用,以及新型免疫检查点阻断剂的意义”[生物医学与药物治疗],第181期(2024):117714。
IF 7.5
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Pub Date : 2026-08-01 Epub Date: 2026-06-19 DOI: 10.1016/j.biopha.2026.119655
Jie Yuan, Li Yang, Hua Zhang, Narasimha M Beeraka, Danfeng Zhang, Qun Wang, Minghua Wang, P R Hemanth Vikram, Gautam Sethi, Geng Wang
{"title":"Retraction notice to \"Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers\" [Biomedicine & Pharmacotherapy 181 (2024) 117714].","authors":"Jie Yuan, Li Yang, Hua Zhang, Narasimha M Beeraka, Danfeng Zhang, Qun Wang, Minghua Wang, P R Hemanth Vikram, Gautam Sethi, Geng Wang","doi":"10.1016/j.biopha.2026.119655","DOIUrl":"10.1016/j.biopha.2026.119655","url":null,"abstract":"","PeriodicalId":93904,"journal":{"name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","volume":" ","pages":"119655"},"PeriodicalIF":7.5,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148284942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to "Corrigendum to "vanillic acid attenuates effects of transient bilateral common carotid occlusion and reperfusion in rats" [Biomed. Pharmacother. 96 (2017) 667-674]" [Biomedicine & Pharmacotherapy 165 (2023) 115061]. 对“香草酸减弱大鼠暂时性双侧颈总动脉闭塞和再灌注效应”的更正撤回通知[生物医学杂志]。生物医药与药物治疗,165(2023)115061。
IF 7.5
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Pub Date : 2026-08-01 Epub Date: 2026-04-27 DOI: 10.1016/j.biopha.2026.119427
Seyed Esmaeil Khoshnam, Alireza Sarkaki, Layasadat Khorsandi, William Winlow, Mohammad Badavi, Hadi Fathi Moghaddam, Yaghoob Farbood
{"title":"Retraction notice to \"Corrigendum to \"vanillic acid attenuates effects of transient bilateral common carotid occlusion and reperfusion in rats\" [Biomed. Pharmacother. 96 (2017) 667-674]\" [Biomedicine & Pharmacotherapy 165 (2023) 115061].","authors":"Seyed Esmaeil Khoshnam, Alireza Sarkaki, Layasadat Khorsandi, William Winlow, Mohammad Badavi, Hadi Fathi Moghaddam, Yaghoob Farbood","doi":"10.1016/j.biopha.2026.119427","DOIUrl":"10.1016/j.biopha.2026.119427","url":null,"abstract":"","PeriodicalId":93904,"journal":{"name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","volume":" ","pages":"119427"},"PeriodicalIF":7.5,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147792104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书